Diaceutics PLC (FRA:7DC)
Germany flag Germany · Delayed Price · Currency is EUR
1.810
+0.010 (0.56%)
At close: Nov 11, 2025

Diaceutics Company Description

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories.

It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports.

In addition, the company offers professional services, such as market landscape, implementation, and consulting services.

It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Diaceutics PLC
CountryUnited Kingdom
Founded2005
IndustryCommercial Physical and Biological Research
Employees199
CEORyan Keeling

Contact Details

Address:
Building Two
Belfast, BT9 6GW
United Kingdom
Websitediaceutics.com

Stock Details

Ticker Symbol7DC
ExchangeFrankfurt Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyGBP
SIC Code8731

Key Executives

NamePosition
Ryan KeelingChief Executive Officer
Nicholas RobertsChief Financial Officer
Kerri DonaldsonChief Operating Officer